Alessandro Colapietro

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma

Giovanni Luca Gravina, Francesco Marampon, Alessandro Colapietro et al. · Journal of Hematology & Oncology · 2017 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage

Francesco Marampon, Giovanni Luca Gravina, Xiaoming Ju et al. · Oncotarget · 2015 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +17

The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma

Claudio Festuccia, Andrea Mancini, Alessandro Colapietro et al. · Journal of Hematology & Oncology · 2018 · 57 citations · Full text

Medicine, Oncology, Pharmacology +15

Crocetin Extracted from Saffron Shows Antitumor Effects in Models of Human Glioblastoma

Alessandro Colapietro, Flora Vitale, Stefano Martellucci et al. · International Journal of Molecular Sciences · 2020 · 55 citations · Full text

Medicine, Oncology, Pharmacology +14

The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models

Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro et al. · Tumor Biology · 2017 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17